News | February 01, 2025
MicrobioTx introduces innovative probiotic range for personalized wellness
These solutions combine scientifically or clinically validated, regulatory-approved probiotic strains with precise dosing
These solutions combine scientifically or clinically validated, regulatory-approved probiotic strains with precise dosing
BRAFTOVI combination regimen is the first and only targeted therapy approvedby the U.S. FDA for treatment-naïve patients with metastatic colorectal cancer with a BRAF V600E mutation
He is an experienced professional in the pharmaceutical industry with about 30 years of progressive experience
Infections with H. pylori affect over 43 percent of the world’s population with a wide range of gastrointestinal disorders
Accelerated approval is based on 61% overall response rate compared to 40% in control arm in the
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
IMKELDI is an advanced liquid formulation of imatinib designed to provide dosing accuracy
Roger Dansey to become Interim Chief Oncology Officer and Johanna Bendell to join Pfizer as Oncology Chief Development Officer
Product basket comprises 2,047 medicines and 300 surgical devices covering all major therapeutic groups
Vonoprazan is used in the treatment of disorders related to Gastroesophageal Reflux Disease (GERD)
Subscribe To Our Newsletter & Stay Updated
